Keywords: long-term, efficacy, pegasys, seen, hcv, first, study

Long-term efficacy of Pegasys seen in HCV

Article | 15 November 2001

Print This

The first long-term study looking at the effectiveness of Roche'sPegasys (peginterferon alfa-2a) in patients with hepatitis C virus infection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in